3901. Medical care for the final years of life: "When you're 83, it's not going to be 20 years".
The case of an 83-year-old man who has had a fall-related injury and continues to be the sole caregiver for his wife who has dementia exemplifies a common situation that clinicians face--planning for the final years of an elderly individual's life. To appropriately focus on the patient's most pressing issues, the approach should begin with an assessment of life expectancy and incorporation of evidence-based care whenever possible. Short-term issues are focused on efforts to restore the patient to his previous state of health. Mid-range issues address providing preventive care, identifying geriatric syndromes, and helping him cope with the psychosocial needs of being a caregiver. Long-term issues relate to planning for his eventual decline and meeting his goals for the end of life. Unfortunately, the workload and inefficiencies of primary care practice present barriers to providing optimal care for older patients. Systematic approaches, including team care, are needed to adequately manage chronic diseases and coordinate care.
3902. Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial.
作者: Beth E Snitz.;Ellen S O'Meara.;Michelle C Carlson.;Alice M Arnold.;Diane G Ives.;Stephen R Rapp.;Judith Saxton.;Oscar L Lopez.;Leslie O Dunn.;Kaycee M Sink.;Steven T DeKosky.; .
来源: JAMA. 2009年302卷24期2663-70页
The herbal product Ginkgo biloba is taken frequently with the intention of improving cognitive health in aging. However, evidence from adequately powered clinical trials is lacking regarding its effect on long-term cognitive functioning.
3904. Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging.
作者: Wolfgang Lieb.;Alexa S Beiser.;Ramachandran S Vasan.;Zaldy S Tan.;Rhoda Au.;Tamara B Harris.;Ronenn Roubenoff.;Sanford Auerbach.;Charles DeCarli.;Philip A Wolf.;Sudha Seshadri.
来源: JAMA. 2009年302卷23期2565-72页
The adipokine leptin facilitates long-term potentiation and synaptic plasticity in the hippocampus, promotes beta-amyloid clearance, and improves memory function in animal models of aging and Alzheimer disease (AD).
3905. Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: a randomized controlled trial.
作者: Robert C Green.;Lon S Schneider.;David A Amato.;Andrew P Beelen.;Gordon Wilcock.;Edward A Swabb.;Kenton H Zavitz.; .
来源: JAMA. 2009年302卷23期2557-64页
Amyloid-beta peptide (Abeta(42)) has been implicated in the pathogenesis of Alzheimer disease (AD). Tarenflurbil, a selective Abeta(42)-lowering agent, demonstrated encouraging results on cognitive and functional outcomes among mildly affected patients in an earlier phase 2 trial.
3906. Relationship of primary care physicians' patient caseload with measurement of quality and cost performance.
作者: David J Nyweide.;William B Weeks.;Daniel J Gottlieb.;Lawrence P Casalino.;Elliott S Fisher.
来源: JAMA. 2009年302卷22期2444-50页
Sufficient numbers of patients are necessary to generate statistically reliable measurements of physicians' quality and cost performance.
3907. Soy food intake and breast cancer survival.
作者: Xiao Ou Shu.;Ying Zheng.;Hui Cai.;Kai Gu.;Zhi Chen.;Wei Zheng.;Wei Lu.
来源: JAMA. 2009年302卷22期2437-43页
Soy foods are rich in isoflavones, a major group of phytoestrogens that have been hypothesized to reduce the risk of breast cancer. However, the estrogen-like effect of isoflavones and the potential interaction between isoflavones and tamoxifen have led to concern about soy food consumption among breast cancer patients.
3908. Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases.
作者: Yun Shin Chun.;Jean-Nicolas Vauthey.;Piyaporn Boonsirikamchai.;Dipen M Maru.;Scott Kopetz.;Martin Palavecino.;Steven A Curley.;Eddie K Abdalla.;Harmeet Kaur.;Chusilp Charnsangavej.;Evelyne M Loyer.
来源: JAMA. 2009年302卷21期2338-44页
The standard criteria used to evaluate tumor response, the Response Evaluation Criteria in Solid Tumors (RECIST), were developed to assess tumor shrinkage after cytotoxic chemotherapy and may be limited in assessing response to biologic agents, which have a cytostatic mechanism of action.
3910. Chronic musculoskeletal pain and the occurrence of falls in an older population.
作者: Suzanne G Leveille.;Richard N Jones.;Dan K Kiely.;Jeffrey M Hausdorff.;Robert H Shmerling.;Jack M Guralnik.;Douglas P Kiel.;Lewis A Lipsitz.;Jonathan F Bean.
来源: JAMA. 2009年302卷20期2214-21页
Chronic pain is a major contributor to disability in older adults; however, the potential role of chronic pain as a risk factor for falls is poorly understood.
3912. Telephone-delivered collaborative care for treating post-CABG depression: a randomized controlled trial.
作者: Bruce L Rollman.;Bea Herbeck Belnap.;Michelle S LeMenager.;Sati Mazumdar.;Patricia R Houck.;Peter J Counihan.;Wishwa N Kapoor.;Herbert C Schulberg.;Charles F Reynolds.
来源: JAMA. 2009年302卷19期2095-103页
Depressive symptoms commonly follow coronary artery bypass graft (CABG) surgery and are associated with less positive clinical outcomes.
3913. Major lipids, apolipoproteins, and risk of vascular disease.
作者: .;Emanuele Di Angelantonio.;Nadeem Sarwar.;Philip Perry.;Stephen Kaptoge.;Kausik K Ray.;Alexander Thompson.;Angela M Wood.;Sarah Lewington.;Naveed Sattar.;Chris J Packard.;Rory Collins.;Simon G Thompson.;John Danesh.
来源: JAMA. 2009年302卷18期1993-2000页
Associations of major lipids and apolipoproteins with the risk of vascular disease have not been reliably quantified.
3915. Health care choices and decisions in the United States and Canada.
Media speculation about the scope of proposals for health care reform in the United States have led many Americans to be “very concerned” that changes will limit their choices in the future (ABC news poll 6/24/09). Health care choices are made on three levels: insurance plans, sources of care (physicians and hospitals), and clinical decisions (diagnostic tests and treatments). In this Commentary, we discuss the extent to which Americans currently are able to exercise choices. For context, we will compare the U.S. environment with that in Canada, partly because its health system, with much greater government involvement, is often publicly-portrayed in the U.S. as limiting choice.
3916. DNA beta-amyloid(1-42) trimer immunization for Alzheimer disease in a wild-type mouse model.
作者: Doris Lambracht-Washington.;Bao-Xi Qu.;Min Fu.;Todd N Eagar.;Olaf Stüve.;Roger N Rosenberg.
来源: JAMA. 2009年302卷16期1796-802页
DNA beta-amyloid(1-42) (Abeta42) trimer immunization was developed to produce specific T helper 2 cell (T(H)2)-type antibodies to provide an effective and safe therapy for Alzheimer disease (AD) by reducing elevated levels of Abeta42 peptide that occur in the brain of patients with AD.
3917. Risk of pancreatic cancer in families with Lynch syndrome.
作者: Fay Kastrinos.;Bhramar Mukherjee.;Nabihah Tayob.;Fei Wang.;Jennifer Sparr.;Victoria M Raymond.;Prathap Bandipalliam.;Elena M Stoffel.;Stephen B Gruber.;Sapna Syngal.
来源: JAMA. 2009年302卷16期1790-5页
Lynch syndrome is an inherited cause of colorectal cancer caused by mutations of DNA mismatch repair (MMR) genes. A number of extracolonic tumors have been associated with the disorder, including pancreatic cancer; however, the risk of pancreatic cancer in Lynch syndrome is uncertain and not quantified.
3918. Geographic access to burn center hospitals.
作者: Matthew B Klein.;C Bradley Kramer.;Jason Nelson.;Frederick P Rivara.;Nicole S Gibran.;Thomas Concannon.
来源: JAMA. 2009年302卷16期1774-81页
The delivery of burn care is a resource-intensive endeavor that requires specialized personnel and equipment. The optimal geographic distribution of burn centers has long been debated; however, the current distribution of centers relative to geographic area and population is unknown.
3919. Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents.
作者: Christoph U Correll.;Peter Manu.;Vladimir Olshanskiy.;Barbara Napolitano.;John M Kane.;Anil K Malhotra.
来源: JAMA. 2009年302卷16期1765-73页
Cardiometabolic effects of second-generation antipsychotic medications are concerning but have not been sufficiently studied in pediatric and adolescent patients naive to antipsychotic medication.
|